Enhancing cisplatin chemosensitivity in gastric cancer through LINC00162 silencing: Modulation of the PI3K/AKT pathway and NANOG downregulation

Introduction: Chemotherapy drugs serve as one of the primary treatments for gastric cancer. However, challenges, including drug resistance and adverse side effects of the chemotherapy drugs like cisplatin, limit their efficacy. Long non-coding RNAs (lncRNAs) have been increasingly recognized as impo...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Seyed Ali Hosseini, Amir Ali Mokhtarzadeh, Saeid Ghorbian, Behzad Baradaran, Changiz Ahmadizadeh
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Tabriz University of Medical Sciences 2026-04-01
Serie:	BioImpacts
Soggetti:	lncrna combination therapy gastric cancer cisplatin apoptosis metastasis
Accesso online:	https://bi.tbzmed.ac.ir/PDF/bi-16-32772.pdf
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!